Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ·Healthcare·Biotechnology
$29.47
-6.58%
Mkt Cap $37.98M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$4.81 | -$3.74 | +22.25% | — | — |
| Q4 2025 Nov 14, 2025 | — | -$4.85M | — | -$4.11 | -$3.62 | +11.92% | — | — |
| Q3 2025 Aug 5, 2025 | — | — | — | -$6.20 | -$3.91 | +36.94% | — | — |
| Q2 2025 May 6, 2025 | — | — | — | -$4.20 | -$5.40 | -28.57% | — | — |
| Q1 2025 Mar 28, 2025 | — | — | — | -$5.40 | -$5.40 | +0.00% | — | — |
| Q4 2024 Nov 14, 2024 | — | — | — | -$6.20 | -$5.80 | +6.45% | — | — |
| Q3 2024 Aug 6, 2024 | — | — | — | -$5.00 | -$5.60 | -12.00% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$5.80 | -$6.40 | -10.34% | — | — |
| Q1 2024 Feb 28, 2024 | — | — | — | -$6.40 | -$6.00 | +6.25% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$5.60 | -$5.60 | +0.00% | — | — |
| Q3 2023 Aug 3, 2023 | — | — | — | -$6.40 | -$6.20 | +3.13% | — | — |
| Q2 2023 May 9, 2023 | — | — | — | -$7.00 | -$6.60 | +5.71% | — | — |
| Q1 2023 Mar 23, 2023 | — | — | — | -$0.40 | -$0.40 | +0.53% | — | — |
| Q4 2022 Nov 8, 2022 | — | — | — | -$7.40 | -$8.80 | -18.92% | — | — |
| Q3 2022 Aug 9, 2022 | — | — | — | -$8.00 | -$6.80 | +15.00% | — | — |
| Q2 2022 May 10, 2022 | — | — | — | -$7.00 | -$8.00 | -14.29% | — | — |
| Q1 2022 Mar 10, 2022 | — | — | — | -$6.80 | -$5.80 | +14.71% | — | — |
| Q4 2021 Nov 9, 2021 | — | — | — | -$5.00 | -$6.40 | -28.00% | — | — |
| Q3 2021 Aug 4, 2021 | — | — | — | -$6.00 | -$6.40 | -6.67% | — | — |
| Q2 2021 May 12, 2021 | — | — | — | -$6.60 | -$8.40 | -27.27% | — | — |